Trial | Sequence generation (selection bias) | Allocation concealment (selection bias) | Blinding of participants and personnel (performance bias) | Blinding of outcome assessors (detection bias) | Completeness of outcome data (attrition bias) | Selective reporting (reporting bias) | Academic bias | Sponsor bias | |
---|---|---|---|---|---|---|---|---|---|
ADOPT, 200620–26 | Low | Low | Low | Low | Low | Low | Low | High | |
Campbell et al., 199427 | Unclear | Unclear | High | High | Low | Unclear | Low | Unclear | |
Collier et al., 198928 | Unclear | Unclear | High | High | Unclear | Unclear | Low | High | |
DeFronzo et al., 199529 | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Low | High | |
Derosa et al., 200442 | Unclear | Unclear | High | High | Low | Unclear | Low | Unclear | |
Hermann et al., 1991a30 | Low | Unclear | High | High | Unclear | Unclear | Low | High | |
Hermann et al., 1991b31–34 | Low | Low | Low | Low | Low | Low | High | High | |
Kamel et al., 199735 | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Low | Unclear | |
Lawrence et al., 200436 | Unclear | Unclear | High | Low | Low | Unclear | Low | High | |
Tang et al., 200441 | Unclear | Unclear | High | High | Unclear | Unclear | Low | Low | |
Tessier et al., 199937 | Unclear | Unclear | High | High | Low | Unclear | Low | High | |
Tosi et al., 200338 | Low | Low | Low | Low | Unclear | Low | Low | High | |
UKPDS 34, 19982,39,40 | Low | Low | High | Low | Unclear | High | Low | High | |
Yamanouchi et al., 200543 | Low | Low | High | High | Low | Unclear | Low | Unclear |
Note: ADOPT = A Diabetes Outcome Progression Trial, UKPDS = United Kingdom Prospective Diabetes Study. *The Cochrane risk-of-bias tool was used to assess the risk of bias for each study. Low risk = bias, if present, is unlikely to alter the results seriously, unclear risk = bias raises some doubt about the results, high risk = bias may alter the results seriously.10